KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 119 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $991,600 | -25.1% | 740,000 | 0.0% | 0.52% | -48.5% |
| Q2 2023 | $1,324,600 | -32.7% | 740,000 | +46.3% | 1.00% | -8.2% |
| Q1 2023 | $1,967,488 | -52.0% | 505,781 | -32.6% | 1.09% | -27.2% |
| Q3 2022 | $4,095,000 | +29.7% | 750,000 | +7.1% | 1.50% | +18.8% |
| Q2 2022 | $3,157,000 | -33.6% | 700,000 | +8.5% | 1.26% | -20.6% |
| Q1 2022 | $4,754,000 | +129.2% | 645,000 | +381.5% | 1.59% | +105.6% |
| Q4 2020 | $2,074,000 | – | 133,951 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |